These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17502453)

  • 1. Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells.
    Ong CJ; Ming-Lum A; Nodwell M; Ghanipour A; Yang L; Williams DE; Kim J; Demirjian L; Qasimi P; Ruschmann J; Cao LP; Ma K; Chung SW; Duronio V; Andersen RJ; Krystal G; Mui AL
    Blood; 2007 Sep; 110(6):1942-9. PubMed ID: 17502453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism.
    An H; Xu H; Zhang M; Zhou J; Feng T; Qian C; Qi R; Cao X
    Blood; 2005 Jun; 105(12):4685-92. PubMed ID: 15701712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 1. Effects on inflammatory cell activation and chemotaxis in vitro and pharmacokinetic characterization in vivo.
    Stenton GR; Mackenzie LF; Tam P; Cross JL; Harwig C; Raymond J; Toews J; Wu J; Ogden N; MacRury T; Szabo C
    Br J Pharmacol; 2013 Mar; 168(6):1506-18. PubMed ID: 23121445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
    Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
    J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of SHIP1 in macrophage programming and activation.
    Rauh MJ; Sly LM; Kalesnikoff J; Hughes MR; Cao LP; Lam V; Krystal G
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):785-8. PubMed ID: 15494015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.
    Zhang J; Walk SF; Ravichandran KS; Garrison JC
    J Biol Chem; 2009 Jul; 284(30):20070-8. PubMed ID: 19494109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages from 11beta-hydroxysteroid dehydrogenase type 1-deficient mice exhibit an increased sensitivity to lipopolysaccharide stimulation due to TGF-beta-mediated up-regulation of SHIP1 expression.
    Zhang TY; Daynes RA
    J Immunol; 2007 Nov; 179(9):6325-35. PubMed ID: 17947710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling.
    Brauer H; Strauss J; Wegner W; Müller-Tidow C; Horstmann M; Jücker M
    Cell Signal; 2012 Nov; 24(11):2095-101. PubMed ID: 22820502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.
    Peng Q; Malhotra S; Torchia JA; Kerr WG; Coggeshall KM; Humphrey MB
    Sci Signal; 2010 May; 3(122):ra38. PubMed ID: 20484116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHIP1 and its role for innate immune regulation-Novel targets for immunotherapy.
    Yeoh WJ; Krebs P
    Eur J Immunol; 2023 Dec; 53(12):e2350446. PubMed ID: 37742135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and insulin-like growth factor-1 promote mast cell survival via activation of the phosphatidylinositol-3-kinase pathway.
    Lessmann E; Grochowy G; Weingarten L; Giesemann T; Aktories K; Leitges M; Krystal G; Huber M
    Exp Hematol; 2006 Nov; 34(11):1532-41. PubMed ID: 17046573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase.
    Bago R; Malik N; Munson MJ; Prescott AR; Davies P; Sommer E; Shpiro N; Ward R; Cross D; Ganley IG; Alessi DR
    Biochem J; 2014 Nov; 463(3):413-27. PubMed ID: 25177796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor-α translation through a SHIP1-dependent pathway.
    Chan CS; Ming-Lum A; Golds GB; Lee SJ; Anderson RJ; Mui AL
    J Biol Chem; 2012 Nov; 287(45):38020-7. PubMed ID: 22955274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.
    Nishio M; Watanabe K; Sasaki J; Taya C; Takasuga S; Iizuka R; Balla T; Yamazaki M; Watanabe H; Itoh R; Kuroda S; Horie Y; Förster I; Mak TW; Yonekawa H; Penninger JM; Kanaho Y; Suzuki A; Sasaki T
    Nat Cell Biol; 2007 Jan; 9(1):36-44. PubMed ID: 17173042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of SHIP1 in T-lymphocyte life and death.
    Gloire G; Erneux C; Piette J
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):277-80. PubMed ID: 17371259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase.
    Waddell GL; Drew EE; Rupp HP; Hansen SD
    J Biol Chem; 2023 Aug; 299(8):105022. PubMed ID: 37423304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible Ser/Thr SHIP phosphorylation: a new paradigm in phosphoinositide signalling?: Targeting of SHIP1/2 phosphatases may be controlled by phosphorylation on Ser and Thr residues.
    Edimo WE; Janssens V; Waelkens E; Erneux C
    Bioessays; 2012 Aug; 34(8):634-42. PubMed ID: 22641604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHIP1 is a repressor of mast cell hyperplasia, cytokine production, and allergic inflammation in vivo.
    Haddon DJ; Antignano F; Hughes MR; Blanchet MR; Zbytnuik L; Krystal G; McNagny KM
    J Immunol; 2009 Jul; 183(1):228-36. PubMed ID: 19542434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Src homology 2-containing inositol 5-phosphatase 1 (SHIP1) is involved in CD32a signaling in human neutrophils.
    Vaillancourt M; Levasseur S; Tremblay ML; Marois L; Rollet-Labelle E; Naccache PH
    Cell Signal; 2006 Nov; 18(11):2022-32. PubMed ID: 16682172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of SHIP1 in bone biology.
    Iyer S; Margulies BS; Kerr WG
    Ann N Y Acad Sci; 2013 Mar; 1280():11-4. PubMed ID: 23551095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.